Understanding Prostate Cancer: What Every Man Should Know

Prostate cancer affects more than 3 million men in the United States, making it the most commonly diagnosed cancer among men. Despite its prevalence, many men remain unaware of the importance of early screening and the advancements that have revolutionized diagnosis and treatment. Dr. Jahan Aghalar, a hematologist-oncologist at New York Cancer & Blood Specialists (NYCBS), is dedicated to empowering men with the knowledge and resources they need to take control of their prostate health.  

“Prostate cancer often progresses silently, without symptoms,” says Dr. Aghalar. “That’s why screening, particularly with PSA (Prostate-Specific Antigen) tests and digital rectal exams, is so crucial especially for men who are 45 and older.” For men with higher risk factors, which include a strong family history of prostate cancer, or who are African American, screening should begin as early as age 40.

In the past, concerns about overtreatment led some organizations to advise against routine screening. However, the medical community now recognizes the importance of smarter, more individualized screening approaches. “Not every prostate cancer requires treatment,” Dr. Aghalar explains. “But when it does, early detection can be absolutely lifesaving.”

Today’s advanced screening tools, such as prostate MRI and fusion-guided biopsy, allow doctors to target suspicious areas with greater accuracy, reducing unnecessary procedures and improving diagnostic precision. These breakthroughs have significantly enhanced the ability to personalize care while minimizing the risks associated with overdiagnosis and subsequent overtreatment.

At NYCBS, patients benefit from a comprehensive, multidisciplinary approach. “We work with experts in radiation oncology, diagnostic imaging, medical oncology, and urology” Dr. Aghalar notes. “This collaborative model ensures patients receive thorough evaluations and customized treatment plans, all close to home.”

Dr. Aghalar also stresses the importance of patients and their loved ones playing an active role in their health. This includes maintaining a personal record of PSA levels, attending regular checkups, asking questions, and staying informed about the latest treatments and research developments regarding prostate cancer.

e“Life after a prostate cancer diagnosis isn’t the end, it’s a new beginning,” says Dr. Aghalar. “With today’s therapies and personalized care, we’re seeing better outcomes and quality of life than ever before.”

For more information about prostate cancer screenings, treatment options, or to schedule a consultation, call 631-751-3000 or visit nycancer.com.

 

Find More Articles